Our Solutions   by Brands   Tucaliv   Dyronib 50 mg Tablets

Dyronib 50 mg Tablets

Dyronib 50Mg Tablet

*To be consumed as directed by physician.

Therapies:

Tyrosine Kinase Inhibitor, Anti Neoplastics

Composition:

Dasatinib 50 mg

About Dyronib 50Mg Tablet

Dyronib 50 mg Tablets contains Dasatinib, an anti-neoplastic used in the treatment of certain blood cancers, including Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) and Ph+ acute lymphoblastic leukaemia (ALL). This drug is classified as a tyrosine kinase inhibitor that works by blocking abnormal proteins responsible for the growth and multiplication of cancer cells. It helps slow disease progression and reduce the spread of malignant cells. It is a prescription medicine and is used only under the supervision of your Oncologist.

Dyronib 50Mg Tablet

*To be consumed as directed by physician.


Usage Instructions

  • Take Dyronib 50 mg Tablets as directed by your oncologist, at a dosage and for a duration suitable for your condition, which may change over time.
  • It can be taken with or without a meal, but try to take it at the same time each day.
  • Do not stop the medicine without consulting your physician, as this can allow the disease to progress.
  • If you forget to take a dose, skip it and resume your normal schedule.
  • Do not double the dose.

    • Benefits and Use

  • Dyronib 50 mg Tablets target the abnormal proteins that cause Philadelphia chromosome-positive leukaemia, helping to slow the growth and spread of malignant cells. 
  • As a selective tyrosine kinase inhibitor, it provides an effective therapy alternative for patients who have not responded well to earlier leukaemia therapies. 

    • Safety Information

  • Pregnancy:
  • Dyronib 50 mg Tablets is not advised during pregnancy as it may cause harm to the developing baby. Inform your physician immediately if you are pregnant or planning to conceive before starting treatment.
  • Breastfeeding:
  • Breastfeeding is not suggested during treatment with Dyronib 50 mg Tablets, as the medicine may pass into breast milk. Consult your physician regarding when it is safe to resume breastfeeding after treatment.
  • Alcohol:
  • Alcohol may increase the risk of certain side effects and may affect your overall health during cancer treatment. Avoid alcohol consumption during the treatment
  • Kidney Disorders:
  • Patients with kidney disorders should use Dyronib 50 mg Tablets cautiously and under close medical supervision. Your physician may monitor your overall health and adjust treatment based on your clinical condition.
  • Liver Disorders:
  • Inform your physician if you have a history of liver disease before starting Dyronib 50 mg Tablets. Regular liver function tests may be recommended during treatment to ensure safe and effective therapy

    • Ingredients

    Dasatinib (50 mg)

    How to Use

  • Swallow the Dyronib 50 mg Tablets with sufficient water.
  • Do not crush or chew it.
  • Consistent use of the medicine as recommended is the key to visible results and in managing your health condition.
  • Follow your physician’s prescribed dosage and attend all scheduled follow-up appointments and blood tests to monitor your response to treatment.

    • Storage Information

    Store below 30°C .